Recent News
On January 22–23, 2026 Amerant reported fourth-quarter 2025 results and outlined a new three‑year strategic plan; management disclosed loan sales closed in January and ongoing credit actions. In February 2026 the board declared a $0.09 quarterly cash dividend payable February 27, 2026 and approved a share repurchase program. Insider filings in February 2026 show restricted stock units vesting for certain executives.
Technical Analysis
Directional indicators: DI+ stands at 24.19 and trends increasing, while DI– reads 16.98 and trends decreasing; this configuration signals a bullish directional bias. ADX at 17.38 remains below 20, indicating no strong trend despite the bullish DI+/DI– setup.
MACD momentum: MACD equals 0.23 with an increasing trend and sits above the signal line at 0.02, representing a bullish MACD cross that supports near-term momentum toward higher prices.
MRO (Momentum/Regression Oscillator): MRO registers −19.91 with an increasing trend, which implies the price sits below model target and presents upside potential as momentum converges upward.
Relative strength: RSI at 55.82 and rising signals moderate bullishness without overbought conditions, supporting continuation of the recent advance rather than an immediate exhaustion.
Price vs moving averages and bands: The closing price $23.22 exceeds the 12‑day EMA ($22.03), 20‑day average ($21.62), 50‑day average ($21.80) and 200‑day average ($19.98), indicating price strength across horizons. Price sits above the 1× Bollinger upper band ($22.54) and just below the 2× upper band ($23.47), signaling elevated placement within the volatility envelope.
Ichimoku and support: Tenkan and Kijun both at $21.67 with Senkou A $22.07 and Senkou B $21.19; the current price sits above the cloud and above the super trend lower support at $21.46, reinforcing short‑term bullish structure.
Volume and volatility: Latest volume (232,979) remains slightly below the 10‑day average (237,580) and well below the 50/200‑day averages, suggesting the recent uptick lacks broad volume confirmation. 42‑day beta 0.81 and 52‑week beta 0.94 point to below‑market to near‑market volatility.
Fundamental Analysis
Earnings: Reported EPS $0.53 exceeded estimate $0.36 by $0.17, representing a 47.22% EPS surprise; forward EPS sits at $0.65875 with a forward P/E of 28.48, signaling expected improvement in earnings power relative to current trailing multiples.
Valuation multiples: Trailing P/E equals 37.08, below the industry peer mean P/E of 43.94 and below the industry peer median of 43.18. Price-to-book equals 0.85, below the industry peer mean book multiple of 1.26 and the median of 1.20, while remaining above the industry peer low of 0.27. Free cash flow yield equals 3.92%, above the industry peer mean free cash flow yield of 2.19%.
Growth and profitability: Reported revenue $96,388,000 with YoY revenue growth at −100.23% and QoQ essentially flat; earnings growth shows +35.90% on the latest figure but the YoY earnings change reads −57.86%. Return on assets equals 0.027% and return on equity equals 0.288%, both down markedly versus prior periods (ROA QoQ −80.99%, ROE QoQ −81.56%), indicating near‑term profitability pressures despite management targets for improvement.
Balance sheet and cash flow: Total assets $9,777,018,000 with cash $463,955,000 and total equity $938,802,000. Debt to assets equals 9.445% and debt to equity equals 98.361%; debt‑to‑assets shows a large YoY percentage change. Operating cash flow $36,482,000 and free cash flow $31,271,000 produce a cash‑flow‑to‑earnings ratio of 1.76, signaling cash conversion strength even amid compressed net income of $2,701,000.
Capital deployment: Management returned capital via a declared $0.09 quarterly dividend (dividend yield ~0.46%) and board authorization for buybacks; dividend coverage ratio reads 0.73 and payout ratio 1.37, indicating the cash dividend carries limited coverage relative to current earnings.
Valuation view: The current valuation as determined by WMDST labels the stock under‑valued given the combination of below‑peer book multiple, above‑peer free cash flow yield, and an improving earnings outlook reflected in forward EPS and forward multiples.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-01-22 |
| NEXT REPORT DATE: | 2026-04-23 |
| CASH FLOW | Begin Period Cash Flow | $ 630.9 M |
| Operating Cash Flow | $ 36.5 M | |
| Capital Expenditures | $ -5.21 M | |
| Change In Working Capital | $ 8.2 M | |
| Dividends Paid | $ -3.69 M | |
| Cash Flow Delta | $ -160.70 M | |
| End Period Cash Flow | $ 470.2 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 96.4 M | |
| Forward Revenue | $ 238.6 M | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | $ 2.1 M | |
| Depreciation and Amortization | $ 2.1 M | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | $ 147.2 M | |
| Interest Expense | $ 57.0 M | |
| Net Interest Income | $ 90.2 M | |
| Income Before Tax | $ 1.9 M | |
| Tax Provision | $ -794.00 K | |
| Tax Rate | 21.0 % | |
| Net Income | $ 2.7 M | |
| Net Income From Continuing Operations | $ 2.7 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.36 | |
| EPS Actual | $ 0.53 | |
| EPS Difference | $ 0.17 | |
| EPS Surprise | 47.222 % | |
| Forward EPS | $ 0.66 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 9.8 B | |
| Intangible Assets | $ 19.2 M | |
| Net Tangible Assets | $ 919.6 M | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | $ 464.0 M | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | $ 342.0 M | |
| Total Debt | $ 923.4 M | |
| Total Liabilities | $ 8.8 B | |
| EQUITY | ||
| Total Equity | $ 938.8 M | |
| Retained Earnings | $ 619.6 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 23.13 | |
| Shares Outstanding | 40.595 M | |
| Revenue Per-Share | $ 2.37 | |
| VALUATION | Market Capitalization | $ 797.8 M |
| Enterprise Value | $ 1.7 B | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | 17.857 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 10.414 | |
| Asset To Liability | 1.106 | |
| Debt To Capital | 0.496 | |
| Debt To Assets | 0.094 | |
| Debt To Assets QoQ | -5.037 % | |
| Debt To Assets YoY | 1463.742 % | |
| Debt To Assets IPRWA | high: 0.11 AMTB: 0.094 median: 0.053 mean: 0.049 low: -0.0 |
|
| Debt To Equity | 0.984 | |
| Debt To Equity QoQ | -10.228 % | |
| Debt To Equity YoY | 1363.705 % | |
| Debt To Equity IPRWA | high: 1.415 AMTB: 0.984 mean: 0.477 median: 0.466 low: -0.002 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 0.85 | |
| Price To Book QoQ | 1.036 % | |
| Price To Book YoY | -20.192 % | |
| Price To Book IPRWA | high: 2.039 mean: 1.264 median: 1.205 AMTB: 0.85 low: 0.274 |
|
| Price To Earnings (P/E) | 37.078 | |
| Price To Earnings QoQ | -24.917 % | |
| Price To Earnings YoY | -17.627 % | |
| Price To Earnings IPRWA | high: 77.079 mean: 43.939 median: 43.18 AMTB: 37.078 low: 30.108 |
|
| PE/G Ratio | 1.033 | |
| Price To Sales (P/S) | 8.276 | |
| Price To Sales QoQ | 13.23 % | |
| Price To Sales YoY | -26.169 % | |
| Price To Sales IPRWA | high: 25.837 mean: 13.438 median: 12.554 AMTB: 8.276 low: 0.123 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 28.476 | |
| Forward PE/G | 0.793 | |
| Forward P/S | 3.344 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.01 | |
| Asset Turnover Ratio QoQ | -8.874 % | |
| Asset Turnover Ratio YoY | 14.371 % | |
| Asset Turnover Ratio IPRWA | high: 0.015 mean: 0.01 median: 0.01 AMTB: 0.01 low: 0.006 |
|
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | -0.054 | |
| CapEx To Depreciation | -2.53 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 1.7 B | |
| Net Invested Capital | $ 1.7 B | |
| Invested Capital | $ 1.7 B | |
| Net Tangible Assets | $ 919.6 M | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 4.541 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | 0.732 | |
| Dividend Payout Ratio | 1.367 | |
| Dividend Rate | $ 0.09 | |
| Dividend Yield | 0.005 | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | -6.082 % | |
| Revenue Growth | -0.381 % | |
| Revenue Growth QoQ | -0.0 % | |
| Revenue Growth YoY | -100.226 % | |
| Revenue Growth IPRWA | high: 23.369 % mean: 3.442 % median: 3.154 % AMTB: -0.381 % low: -10.947 % |
|
| Earnings Growth | 35.897 % | |
| Earnings Growth QoQ | -213.674 % | |
| Earnings Growth YoY | -57.86 % | |
| Earnings Growth IPRWA | high: 44.444 % AMTB: 35.897 % mean: 3.084 % median: 2.632 % low: -25.0 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 31.3 M | |
| Free Cash Flow Yield | 3.92 % | |
| Free Cash Flow Yield QoQ | 31.367 % | |
| Free Cash Flow Yield YoY | -51.575 % | |
| Free Cash Flow Yield IPRWA | high: 7.476 % AMTB: 3.92 % median: 2.306 % mean: 2.193 % low: -3.012 % |
|
| Free Cash Growth | 31.862 % | |
| Free Cash Growth QoQ | -155.086 % | |
| Free Cash Growth YoY | -98.886 % | |
| Free Cash Growth IPRWA | high: 176.765 % AMTB: 31.862 % mean: -2.923 % median: -9.484 % low: -234.402 % |
|
| Free Cash To Net Income | 11.578 | |
| Cash Flow Margin | 4.939 % | |
| Cash Flow To Earnings | 1.763 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.04 | |
| Return On Assets (ROA) | 0.027 % | |
| Return On Assets QoQ | -80.986 % | |
| Return On Assets YoY | -83.832 % | |
| Return On Assets IPRWA | high: 0.519 % median: 0.311 % mean: 0.308 % AMTB: 0.027 % low: -0.023 % |
|
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | 0.003 | |
| Return On Equity QoQ | -81.562 % | |
| Return On Equity YoY | -84.81 % | |
| Return On Equity IPRWA | high: 0.047 mean: 0.028 median: 0.028 low: 0.006 AMTB: 0.003 |
|
| DuPont ROE | 0.287 % | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |